131 related articles for article (PubMed ID: 37054526)
1. Vitamin D analog calcitriol for breast cancer therapy; an integrated drug discovery approach.
B S N; P K KN; Akey KS; Sankaran S; Raman RK; Natarajan J; Selvaraj J
J Biomol Struct Dyn; 2023 Dec; 41(20):11017-11043. PubMed ID: 37054526
[TBL] [Abstract][Full Text] [Related]
2. Effect of Calcitriol in Inhibiting the Cancer Cell Growth and Promoting Apoptosis in ErbB2-positive Breast Cancer Cells.
Selvaraj NB; Swaroop AK; Mariappan E; Natarajan J; Thangavelu P; Selvaraj J
Anticancer Agents Med Chem; 2023; 23(18):2056-2071. PubMed ID: 37608657
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells.
Brockhoff G; Heiss P; Schlegel J; Hofstaedter F; Knuechel R
Cytometry; 2001 Aug; 44(4):338-48. PubMed ID: 11500850
[TBL] [Abstract][Full Text] [Related]
4. The addition of calcitriol or its synthetic analog EB1089 to lapatinib and neratinib treatment inhibits cell growth and promotes apoptosis in breast cancer cells.
Segovia-Mendoza M; Díaz L; Prado-Garcia H; Reginato MJ; Larrea F; García-Becerra R
Am J Cancer Res; 2017; 7(7):1486-1500. PubMed ID: 28744399
[TBL] [Abstract][Full Text] [Related]
5. The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancer.
Krishnan AV; Swami S; Feldman D
Steroids; 2012 Sep; 77(11):1107-12. PubMed ID: 22801352
[TBL] [Abstract][Full Text] [Related]
6. Calcitriol and its analogues enhance the antiproliferative activity of gefitinib in breast cancer cells.
Segovia-Mendoza M; Díaz L; González-González ME; Martínez-Reza I; García-Quiroz J; Prado-Garcia H; Ibarra-Sánchez MJ; Esparza-López J; Larrea F; García-Becerra R
J Steroid Biochem Mol Biol; 2015 Apr; 148():122-31. PubMed ID: 25510900
[TBL] [Abstract][Full Text] [Related]
7. Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers.
Roskoski R
Pharmacol Res; 2019 Jan; 139():395-411. PubMed ID: 30500458
[TBL] [Abstract][Full Text] [Related]
8. Potential target identification for breast cancer and screening of small molecule inhibitors: A bioinformatics approach.
Agarwal S; Kashaw SK
J Biomol Struct Dyn; 2021 Apr; 39(6):1975-1989. PubMed ID: 32186248
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D receptor as a target for breast cancer therapy.
Murray A; Madden SF; Synnott NC; Klinger R; O'Connor D; O'Donovan N; Gallagher W; Crown J; Duffy MJ
Endocr Relat Cancer; 2017 Apr; 24(4):181-195. PubMed ID: 28213567
[TBL] [Abstract][Full Text] [Related]
10. A High Dose of Calcitriol Inhibits Glycolysis and M2 Macrophage Polarization in the Tumor Microenvironment by Repressing mTOR Activation: in vitro and Molecular Docking Studies.
Munir MT; Halim SA; Santos JM; Khan F; Khan A; Rahman MM; Hussain F; Al-Harrasi A; Gollahon LS; Rahman SM
Cell Physiol Biochem; 2023 Apr; 57(2):105-122. PubMed ID: 37052042
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Mouse Breast Tumor-Initiating Cells by Calcitriol and Dietary Vitamin D.
Jeong Y; Swami S; Krishnan AV; Williams JD; Martin S; Horst RL; Albertelli MA; Feldman BJ; Feldman D; Diehn M
Mol Cancer Ther; 2015 Aug; 14(8):1951-61. PubMed ID: 25934710
[TBL] [Abstract][Full Text] [Related]
12. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of vitamin D treatment on inflammatory and non-inflammatory breast cancer cell lines.
Hillyer RL; Sirinvasin P; Joglekar M; Sikes RA; van Golen KL; Nohe A
Clin Exp Metastasis; 2012 Dec; 29(8):971-9. PubMed ID: 22610818
[TBL] [Abstract][Full Text] [Related]
14. Structural analysis and biological activities of BXL0124, a gemini analog of vitamin D.
Belorusova AY; Suh N; Lee HJ; So JY; Maehr H; Rochel N
J Steroid Biochem Mol Biol; 2017 Oct; 173():69-74. PubMed ID: 27650654
[TBL] [Abstract][Full Text] [Related]
15. Equivalent anticancer activities of dietary vitamin D and calcitriol in an animal model of breast cancer: importance of mammary CYP27B1 for treatment and prevention.
Krishnan AV; Swami S; Feldman D
J Steroid Biochem Mol Biol; 2013 Jul; 136():289-95. PubMed ID: 22939886
[TBL] [Abstract][Full Text] [Related]
16. Discovery of potential HER2 inhibitors from
Balogun TA; Iqbal MN; Saibu OA; Akintubosun MO; Lateef OM; Nneka UC; Abdullateef OT; Omoboyowa DA
J Biomol Struct Dyn; 2022; 40(23):12772-12784. PubMed ID: 34514973
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in silico anticancer activity of amygdalin on the SK-BR-3 human breast cancer cell line.
Moradipoodeh B; Jamalan M; Zeinali M; Fereidoonnezhad M; Mohammadzadeh G
Mol Biol Rep; 2019 Dec; 46(6):6361-6370. PubMed ID: 31583572
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of a novel analog of calcitriol and its biological evaluation as antitumor agent.
Ferronato MJ; Obiol DJ; Alonso EN; Guevara JA; Grioli SM; Mascaró M; Rivadulla ML; Martínez A; Gómez G; Fall Y; Quevedo MA; Curino AC; Facchinetti MM
J Steroid Biochem Mol Biol; 2019 Jan; 185():118-136. PubMed ID: 30125657
[TBL] [Abstract][Full Text] [Related]
19. The ErbB/HER family of protein-tyrosine kinases and cancer.
Roskoski R
Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.
Diermeier S; Horváth G; Knuechel-Clarke R; Hofstaedter F; Szöllosi J; Brockhoff G
Exp Cell Res; 2005 Apr; 304(2):604-19. PubMed ID: 15748904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]